JP2011507859A5 - - Google Patents

Download PDF

Info

Publication number
JP2011507859A5
JP2011507859A5 JP2010539516A JP2010539516A JP2011507859A5 JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5 JP 2010539516 A JP2010539516 A JP 2010539516A JP 2010539516 A JP2010539516 A JP 2010539516A JP 2011507859 A5 JP2011507859 A5 JP 2011507859A5
Authority
JP
Japan
Prior art keywords
connexin
composition
polynucleotide
oligonucleotide
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010539516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011507859A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/014024 external-priority patent/WO2009085273A2/en
Publication of JP2011507859A publication Critical patent/JP2011507859A/ja
Publication of JP2011507859A5 publication Critical patent/JP2011507859A5/ja
Pending legal-status Critical Current

Links

JP2010539516A 2007-12-21 2008-12-22 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用 Pending JP2011507859A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US874807P 2007-12-21 2007-12-21
PCT/US2008/014024 WO2009085273A2 (en) 2007-12-21 2008-12-22 Use of anti-connexin polynucleotides for the treatment of surgical adhesions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2014173528A Division JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Publications (2)

Publication Number Publication Date
JP2011507859A JP2011507859A (ja) 2011-03-10
JP2011507859A5 true JP2011507859A5 (https=) 2013-04-25

Family

ID=40824957

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010539516A Pending JP2011507859A (ja) 2007-12-21 2008-12-22 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用
JP2014173528A Pending JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2014173528A Pending JP2015013880A (ja) 2007-12-21 2014-08-28 外科的癒着の治療のための抗コネキシンポリヌクレオチドの使用

Country Status (7)

Country Link
US (1) US20110144182A1 (https=)
EP (1) EP2252689A2 (https=)
JP (2) JP2011507859A (https=)
AU (1) AU2008343754A1 (https=)
CA (1) CA2710227A1 (https=)
WO (1) WO2009085273A2 (https=)
ZA (1) ZA201005220B (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1959981T3 (da) 2005-02-03 2020-01-27 Coda Therapeutics Ltd Anti-connexin 43 forbindelser til behandling af kroniske sår
US8975237B2 (en) 2007-12-21 2015-03-10 Coda Therapeutics, Inc. Treatment of fibrotic conditions
CN102985096B (zh) * 2010-04-13 2014-12-10 凯希特许有限公司 具有活性成分的组合物以及伤口敷料、设备和方法
CA2866115C (en) 2012-03-01 2020-03-24 Firststring Research, Inc. Topical gels containing alpha connexin c-terminal (act) peptides
CA2868534A1 (en) 2012-03-27 2013-10-03 Coda Therapeutics, Inc. Compositions and treatments based on cadherin modulation
US20130259854A1 (en) * 2012-04-02 2013-10-03 Saint Louis University, A Non-Profit Organization Methods and compositions for reducing the incidence of post-surgical adhesions
US10465188B2 (en) 2014-08-22 2019-11-05 Auckland Uniservices Limited Channel modulators
CN111201247A (zh) 2017-04-28 2020-05-26 奥克兰联合服务有限公司 治疗方法和新颖构建体
JP2023546757A (ja) 2020-10-22 2023-11-07 シークエル・バイオ・インコーポレイテッド ペプチド製剤および眼科におけるその使用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687808A (en) * 1969-08-14 1972-08-29 Univ Leland Stanford Junior Synthetic polynucleotides
US5034506A (en) * 1985-03-15 1991-07-23 Anti-Gene Development Group Uncharged morpholino-based polymers having achiral intersubunit linkages
US4861757A (en) * 1986-11-14 1989-08-29 Institute Of Molecular Biology Wound healing and bone regeneration using PDGF and IGF-I
JPH0539594Y2 (https=) * 1988-08-05 1993-10-07
US5166195A (en) * 1990-05-11 1992-11-24 Isis Pharmaceuticals, Inc. Antisense inhibitors of the human immunodeficiency virus phosphorothioate oligonucleotides
US6752987B1 (en) * 1995-02-28 2004-06-22 The Regents Of The University Of California Adenovirus encoding human adenylylcyclase (AC) VI
US20030148968A1 (en) * 1995-02-28 2003-08-07 Hammond H. Kirk Techniques and compositions for treating cardiovascular disease by in vivo gene delivery
AU9016898A (en) * 1997-08-07 1999-03-01 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The Methods and compositions for treatment of restenosis
EP1037981A1 (en) * 1997-12-09 2000-09-27 Children's Medical Center Corporation Soluble inhibitors of vascular endothelial growth factor and use thereof
US6506559B1 (en) * 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
DK1146908T3 (da) * 1999-01-27 2005-10-10 Becker David Dr Formuleringer omfattende antisense-nukleotider mod connexiner
US5998148A (en) * 1999-04-08 1999-12-07 Isis Pharmaceuticals Inc. Antisense modulation of microtubule-associated protein 4 expression
JP2004531461A (ja) * 2000-10-18 2004-10-14 チルドレンズ メディカル センター コーポレーション オステオポンチン被覆表面および使用方法
US20050119211A1 (en) * 2001-05-18 2005-06-02 Sirna Therapeutics, Inc. RNA mediated inhibition connexin gene expression using short interfering nucleic acid (siNA)
WO2003032964A2 (en) * 2001-10-17 2003-04-24 University Of Wales College Of Medecine Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
HRP20040784A2 (en) * 2002-01-29 2005-04-30 Wyeth Compositions and methods for modulating connexin hemichannels
WO2003096981A2 (en) * 2002-05-15 2003-11-27 Seul, Kyung, Hwan Method of modulating angiogenesis
US8809504B2 (en) * 2002-09-03 2014-08-19 Vit Lauermann Inhibitor which is deactivatable by a reagent produced by a target cell
WO2006006948A2 (en) * 2002-11-14 2006-01-19 Dharmacon, Inc. METHODS AND COMPOSITIONS FOR SELECTING siRNA OF IMPROVED FUNCTIONALITY
CA3059497A1 (en) * 2003-12-03 2005-06-16 Ocunexus Therapeutics, Inc. Antisense compounds targeted to connexins and methods of use thereof
CA2989941A1 (en) * 2004-09-23 2006-03-30 Arc Pharmaceuticals, Inc. Pharmaceutical compostions and methods relating to inhibiting fibrous adhesions or inflammatory disease using low sulphate fucans
DK1959981T3 (da) * 2005-02-03 2020-01-27 Coda Therapeutics Ltd Anti-connexin 43 forbindelser til behandling af kroniske sår
EA200870058A1 (ru) * 2005-12-16 2008-12-30 Арла Фудс Амба Композиции, содержащие остеопонтин крупного рогатого скота, для улучшения процесса заживления ран
EP2114422A1 (en) * 2007-03-02 2009-11-11 National University of Ireland, Galway Osteopontin for the prediction and treatment of cardiovascular diseases
EP2245158A2 (en) * 2007-12-11 2010-11-03 Coda Therapeutics, Inc. Impaired wound healing compositions and treatments

Similar Documents

Publication Publication Date Title
JP2011507859A5 (https=)
JP5607176B2 (ja) 新規ペプチドおよびその用途
US8668703B2 (en) Medical devices incorporating collagen inhibitors
US20090180965A1 (en) Methods for repair and regeneration of bone marrow
JP4307561B2 (ja) 創傷の治癒
JP2011507858A5 (https=)
US9782522B2 (en) Compositions and methods for treating and preventing neointimal stenosis
KR20120014251A (ko) 동종이식편의 접합을 개선하기 위한 생체활성 코팅 조성물 및 방법
JP2011507855A5 (https=)
Hildebrand et al. Joint capsule matrix turnover in a rabbit model of chronic joint contractures: correlation with human contractures
CN105078889B (zh) 一种用于治疗软骨疾病的脂质体递送系统及其制备方法
DE602005025347D1 (de) Oligoribonukleotide und verfahren zu deren anwendung bei der behandlung von fibrotischen leiden und anderen krankheiten
WO2013059879A1 (en) Compositions and methods for the treatment of fibrosis and fibrotic diseases
WO2007092833A3 (en) Drug delivery stent with extended in vivo drug release
KR20240105439A (ko) 건-골 계면의 복구를 위한 방법 및 조성물
TW201023879A (en) Method of inhibiting and/or rescuing cell terminal differentiation, and composition for treating and/or inhibiting arthritis
JP7514563B2 (ja) オルガノイドおよび抗炎症剤を含む炎症性腸疾患の予防または治療用薬学組成物
RU2425669C1 (ru) Средство для профилактики и лечения острого и хронического панкреатита
US20180214388A1 (en) Composition and method for reducing scarring
CN103948617A (zh) 一种治疗和预防腹部手术后粘连的药物组合物
CN104644620B (zh) 化合物xl‑001在制备治疗慢性肾脏病的药物中的用途
US10596192B2 (en) Treating rotator cuff conditions
CN115120729B (zh) 跨膜蛋白41b作为药物靶标在制备治疗病理性心肌肥厚药物中的应用
CN118217295A (zh) 25-羟基胆固醇在制备骨质疏松和骨溶解症治疗药物中的应用
DE502007003367D1 (de) Pharmazeutische zusammensetzung zur behandlung von inkontinenz